Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma
Publication
, Conference
Choi, T; Kodali, MK; Weng, W-K
Published in: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
2017
Duke Scholars
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
2017
Volume
23
Issue
3
Start / End Page
S213 / S214
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Choi, T., Kodali, M. K., & Weng, W.-K. (2017). Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma. In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (Vol. 23, pp. S213–S214).
Choi, Taewoong, Murali K. Kodali, and Wen-Kai Weng. “Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma.” In BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23:S213–14, 2017.
Choi T, Kodali MK, Weng W-K. Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma. In: BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017. p. S213–4.
Choi, Taewoong, et al. “Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma.” BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 23, no. 3, 2017, pp. S213–14.
Choi T, Kodali MK, Weng W-K. Hematopoietic Cell Transplantation Provides Durable Disease Control in Patients with Double-Hit Lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017. p. S213–S214.
Published In
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
EISSN
1523-6536
ISSN
1083-8791
Publication Date
2017
Volume
23
Issue
3
Start / End Page
S213 / S214
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences